Progress in SARS and MERS vaccines: lessons for the development of COVID-19 vaccine
10.3760/cma.j.cn112309-20200303-00096
- VernacularTitle: SARS和MERS疫苗研究进展综述:COVID-19疫苗研究的借鉴
- Author:
Xingui TIAN
1
;
Rong ZHOU
1
Author Information
1. State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510182, China
- Publication Type:Journal Article
- Keywords:
SARS-CoV-2;
COVID-19;
SARS;
MERS;
Vaccine
- From:
Chinese Journal of Microbiology and Immunology
2020;40(0):E009-E009
- CountryChina
- Language:Chinese
-
Abstract:
Safe and effective vaccines are urgently needed to prevent and control the outbreak of COVID-19. SARS-CoV-2 belongs to the genus Betacoronavirus like severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Here we summarized the current progress and problems in the development of vaccines against SARS-CoV and MERS-CoV in order to provide reference for COVID-19 vaccine development.